ActRII receptor polypeptides, methods and compositions

Details for Australian Patent Application No. 2005266875 (hide)

Owner Acceleron Pharma Inc.

Inventors Knopf, John; Seehra, Jasbir

Agent Shelston IP

Pub. Number AU-B-2005266875

PCT Pub. Number WO2006/012627

Priority 60/590,765 23.07.04 US

Filing date 25 July 2005

Wipo publication date 2 February 2006

Acceptance publication date 26 July 2012

International Classifications

C07K 14/705 Peptides having more than 20 amino acids

A61K 38/00 Medicinal preparations containing peptides

A61K 38/17 Medicinal preparations containing peptides - from animals

A61P 19/00 Drugs for skeletal disorders

A61P 21/00 Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 Drugs for disorders of the nervous system

C12N 15/00 Mutation or genetic engineering

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/012627 Priority application(s): WO2006/012627

26 July 2012 Application Accepted

  Published as AU-B-2005266875

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005266882-Dosage forms with an enterically coated core tablet

2005266863-Lysine citrate for plasma protein and donor protection